From Disease to Pregnancy: Rethinking Cardiac Remodeling Through Fibroblast, Immune Cell, and Hormonal Interactions

Area of Science:

• Cardiovascular Physiology
• Reproductive Endocrinology
• Fibrosis Research

Background:

• Cardiac fibrosis, marked by fibroblast activation and excessive extracellular matrix deposition, drives heart failure progression.
• Physiological cardiac remodeling, unlike pathological remodeling, allows adaptive growth without net fibrosis.
• Pregnancy presents an underexplored physiological model of reversible cardiac remodeling and fibrosis resistance.

Purpose of the Study:

• To explore pregnancy as a model of fibrosis-resistant cardiac adaptation.
• To investigate the role of hormonal milieu in suppressing profibrotic pathways during pregnancy and lactation.
• To identify endogenous anti-fibrotic mechanisms and potential therapeutic targets for cardiac fibrosis.

Main Methods:

• Review of existing literature on maternal cardiac remodeling during pregnancy and postpartum.
• Analysis of hormonal and immune reprogramming in maternal tissues.
• Focus on non-myocyte cardiac cells and extracellular matrix dynamics.

Main Results:

• The maternal heart undergoes adaptive hypertrophic growth during pregnancy that resolves postpartum, demonstrating fibrosis resistance.
• Pregnancy involves endocrine and immune reprogramming, suggesting a hormonal milieu that suppresses profibrotic pathways.
• Candidate hormones (estrogen, progesterone, prolactin, relaxin, oxytocin) and the renin-angiotensin-aldosterone system are implicated in maintaining extracellular matrix homeostasis.

Conclusions:

• Pregnancy serves as a natural paradigm for fibrosis-resistant cardiac remodeling.
• Hormonal crosstalk among cardiac cells suppresses profibrotic signaling, preserving extracellular matrix integrity.
• Understanding these endogenous mechanisms can lead to novel therapeutic strategies for treating cardiac fibrosis and heart failure.